Marley V. Ghizzone is a journalist who writes for Healio, focusing on medical and healthcare topics. Marley's articles cover a range of subjects, including the prevalence and treatment of hepatitis C, advancements in transplant protocols, and developments in cancer treatment.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Marley V. Ghizzone's articles predominantly focus on healthcare and pharmaceuticals, particularly in relation to specific diseases such as hepatitis C and acute myeloid leukemia. Based on the coverage attributes, Marley seems receptive to pitches offering data-driven insights or expert commentary related to advancements in treatments for these conditions.
Given the high percentage of articles citing data and including expert commentary, it is likely that she would be interested in receiving information from credible sources who can provide statistical evidence or professional opinions regarding new developments in healthcare, pharmaceuticals, and treatment protocols for various medical conditions.
Although there is no specified geographic focus, considering that some articles mention UK programs, providing insights into relevant global trends may also be beneficial when reaching out with potential story ideas.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Jeffrey A. Sparks, Marley V. Ghizzone
WASHINGTON — In this video, Jeffrey A. Sparks , MD , MMSc highlights an observational study investigating the impact of disease-modifying antirheumatic drugs on rheumatoid arthritis-associated interstitial lung disease.
By: Jeffrey A. Sparks, Marley V. Ghizzone
WASHINGTON — Healio spoke with Jeffrey A. Sparks , MD MMSc about baseline results from the SAIL-RA study, which assesses which patients with rheumatoid arthritis may be at risk for developing interstitial lung disease.
Video Player is loading. Play Video Play Mute Current Time Duration
By: Marley V. Ghizzone, Micaela Bayard
WASHINGTON — Micaela F. Bayard , MD, spoke with Healio about the management of steroids and how this topic was covered at ACR Convergence 2024.
By: Micaela Bayard, Marley V. Ghizzone, Shenaz Bagha
Video Player is loading. Play Video Play Mute Current Time Duration Loaded
By: Micaela Bayard, Marley V. Ghizzone, Shenaz Bagha
Video Player is loading. Play Video Play Mute Current Time Duration
By: Namrata Singh, Shenaz Bagha, Marley V. Ghizzone
WASHINGTON — In this video, Namrata Singh, MD, MSCI spotlights three important abstracts in rheumatoid arthritis presented at ACR Convergence 2024.
By: Marley V. Ghizzone, Namrata Singh
WASHINGTON — In this video, Namrata Singh, MD, MSCI highlights two posters from her team investigating associations between cancer and rheumatoid arthritis, led by “rising stars.”
By: Namrata Singh, Marley V. Ghizzone
Video Player is loading. Play Video Play Mute Current Time Duration Loaded
By: Marley V. Ghizzone, Ambreesh Chawla, Shenaz Bagha
WASHINGTON — In this video, Ambreesh Chawla, MD summarizes salient and practice-changing presentations in rheumatoid arthritis from ACR Convergence 2024.
(833) 317-6278 